News and analysis for the global poultry industry.

MSD Animal Health COBACTAN LA 7.5% antibiotic

Contact Information

Phone: +31.485.587600


MSD Animal Health
Postbus 31
5830 AA

MSD Animal Health (known as Merck Animal Health in the U.S. and Canada) recently obtained regulatory approval in 21 European countries for COBACTAN LA 7.5% (cefquinome) - a new-generation, injectable antimicrobial for the treatment of swine respiratory disease. MSD COBACTAN LA 7.5% is a long-acting version of the company's COBACTAN 2.5%, offering greater compliance for swine producers with fewer injections and less stress to the animals. The long-acting antibiotic formulation is effective against Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida.

Back to listings